Patent · US Active

Tuberculosis treatment using pleuromutilin derivatives

US8088823B2 · kind B2 · utility

1Cited by

3References

2Claims

0Family size

Assignee

NABRIVA THERAPEUTICS GMBH · AT

Inventors

Gerd Ascher · Kundl, AT
Heinz Berner · Pressbaum, AT
Rosemarie Mang · Wien, AT

Key dates

Filing date	Jun 13, 2007
Grant date	Jan 3, 2012
Priority date	—
Expiry date	Jul 10, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D493/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of preventing or treating diseases caused by Mycobacterium, comprising administering to a subject in need of such treatment an effective amount of a pleuromutilin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.